News | Digital Radiography (DR) | February 10, 2016

Guitar Maker and Partners Launch Image, Sound Waveform Technology Company

Patented image technology develops sharper X-ray images with significantly less radiation exposure

Digital Harmonic, X-ray technology, Paul Reed Smith

Standard x-ray image before (left) and after (right) Digital Harmonic's technology is applied. Image courtesy of Business Wire.

February 10, 2016 — Legendary guitar maker Paul Reed Smith, founder of PRS Guitars, is part of a group that launched a new technology in November to develop enhanced sharper X-rays while significantly reducing radiation exposure to patients and medical providers. The group includes a team of renowned scientists and physicians and a former commissioner of the U.S. Food and Drug Administration (FDA). 

The new company, Digital Harmonic LLC, has developed a proprietary and patented image and waveform technology that aims to revolutionize how the medical community implements X-rays. The company has already raised $5 million and is seeking to raise another $5 million to fund its growth.

The technology is the result of a decade of research that started with Paul Reed Smith’s late father Jack Smith, an applied mathematician. Combining his understanding of precision mathematics and physics together with his son Paul’s understanding of sound and harmonics from guitar making created the technology.

“We figured out how to extract previously undetected data out of complex sound waveforms and then applied that new theory to create remarkably detailed images,” said Smith. “The potential for the medical community to be able to get much more precise images is exciting.”

Smith continued, “Most existing medical solutions are either chemical, radiation or mechanical. This new approach proposes a mathematical and physics solution for medicine.”

Digital Harmonic has assembled an advisory board of nationally prominent scientists and medical experts who will help guide the development of its products, including:

  • Andrew C. von Eschenbach president, Samaritan Health Initiatives Inc., former head of the FDA, and former director, National Cancer Institute;
  • William G. Nelson, M.D., Ph.D., director of the Sidney Kimmel Cancer Center at Johns Hopkins Medical Center;
  • Theodore DeWeese, M.D. professor and chairman of radiation oncology and molecular radiation sciences, Johns Hopkins;
  • John Wong, Ph.D., professor of radiation oncology and molecular radiation sciences, Johns Hopkins;
  • Alex Szalay, Ph.D, professor of astrophysics and computer sciences, Johns Hopkins;
  • Srinivasan Yegnasubramanian, associate professor of oncology, Johns Hopkins;
  • Elliott McVeigh, Ph.D., professor, bioengineering, University of California San Diego;
  • Paul Reed Smith, general managing partner-PRS Guitars and a principal inventor of the company’s proprietary technology; and,
  • Michael C. Hibler, MPA, director of development, Johns Hopkins.

In addition to developing the technology for increasing image resolution for X-rays, the company expects to utilize its patented image, sound and analytic abilities to manufacture products to aid other diagnostic technologies in addition to X-rays.

Smith said the company’s proprietary technology could also have wide applications in the defense community, which relies on access to precise image analysis. The company is currently in contract negotiations with a major defense contractor for the U.S. Navy.

Digital Harmonic LLC commenced operations upon achieving its minimum funding requirement of $5 million. The company will continue to accept subscriptions for additional units until it reaches its maximum initial funding of $10 million. According to a Private Placement Memorandum, each unit is $500,000, which may be fractionalized at the company’s discretion.

For more information: www.digitalharmonic.com

Related Content

#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 Doctor in our hospital is using this intelligent system for accurate diagnosis

Doctor in our hospital is using this intelligent system for accurate diagnosis. (Photo: Business Wire)

News | Artificial Intelligence | March 31, 2020
March 31, 2020 — The Intelligent Evalua...
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2
News | Coronavirus (COVID-19) | March 31, 2020
March 31, 2020 — In a...
AI tool predicts which patients newly infected with COVID-19 will eventually develop severe respiratory disease #COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2
News | Artificial Intelligence | March 31, 2020
March 31, 2020 — An artificial intelligence tool accurately predicted which patients newly infected with the...
RSNA's open data repository will compile images and correlative data to create a comprehensive source for COVID-19 research and education efforts #COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2
News | Coronavirus (COVID-19) | March 30, 2020
March 30, 2020 — The medical imaging community around the world is uniting to help address the...
Phase III response to the COVID-19 public health emergency (PHE) CARES Act signed into law #CARESAct #COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2
Feature | Coronavirus (COVID-19) | March 28, 2020 | By Melinda Taschetta-Millane
On March 27, the House of Representatives approved a historic $2
AI vendor Infervision's InferRead CT Pneumonia software uses artificial intelligence-assisted diagnosis to improve the overall efficiency of the radiology department. It is being developed in China as a high sensitivity detection aid for novel coronavirus pneumonia (COVID-19). #COVID19 #coronavirus #SARScov2

AI vendor Infervision's InferRead CT Pneumonia software uses artificial intelligence-assisted diagnosis to improve the overall efficiency of the radiology department. It is being developed in China as a high sensitivity detection aid for novel coronavirus pneumonia (COVID-19).

Feature | Coronavirus (COVID-19) | March 27, 2020 | Jilian Liu, M.D., HIMSS Greater China
An older couple walked into the Hubei Provincial Hospital of Integrated Chinese and Western Medicine near their neigh
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2

Typical CT imaging features for COVID-19. Unenhanced, thin-section axial images of the lungs in a 52-year-old man with a positive RT-PCR (A-D) show bilateral, multifocal rounded (asterisks) and peripheral GGO (arrows) with superimposed interlobular septal thickening and visible intralobular lines (“crazy-paving”). Routine screening CT for diagnosis or exclusion of COVID-19 is currently not recommended by most professional organizations or the US Centers for Disease Control and Prevention. Image courtesy of RSNA

News | Coronavirus (COVID-19) | March 26, 2020
March 26, 2020 — The Radiological Society of North America (RSNA
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2
News | Coronavirus (COVID-19) | March 25, 2020
March 25, 2020 — According to a statement on March 24 from Commissioner of Food and Drugs - Food and Drug Administrat